Why the study?
Does percutaneous pulmonary valve implantation (PPVI) improve haemodynamics and quality of life in patients with dysfunctional pulmonary valve conduits?
Population
71 patients with dysfunctional pulmonary valve conduits, median age 19.0 [IQR: 14.0 to 25.0] years, 24…
Design
Cohort
Follow-up
five years
Authors
Loading...
Five-year PPVI data support sustained benefits in selected patients; leaves open need for randomized trials versus surgery.
Does percutaneous pulmonary valve implantation (PPVI) improve haemodynamics and quality of life in patients with dysfunctional pulmonary valve conduits?
Percutaneous pulmonary valve implantation provides sustained haemodynamic and quality of life improvements at 5 years in patients with dysfunctional pulmonary valve conduits, though restenosis requiring treatment occurs in a subset.
Hager et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: